Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2015, Article ID 905097, 4 pages
http://dx.doi.org/10.1155/2015/905097
Case Report

Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate

1Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark
2Department of Psychiatry, Aarhus University Hospital, Risskov Skovagervej 2, 8240 Risskov, Denmark

Received 24 April 2015; Revised 16 June 2015; Accepted 16 June 2015

Academic Editor: Bibhuti Das

Copyright © 2015 Kim Munk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. O. Cooper, L. A. Habel, C. M. Sox et al., “ADHD drugs and serious cardiovascular events in children and young adults,” The New England Journal of Medicine, vol. 365, no. 20, pp. 1896–1904, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. E. Nissen, “ADHD drugs and cardiovascular risk,” The New England Journal of Medicine, vol. 354, no. 14, pp. 1445–1448, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Schelleman, W. B. Bilker, S. E. Kimmel et al., “Methylphenidate and risk of serious cardiovascular events in adults,” The American Journal of Psychiatry, vol. 169, no. 2, pp. 178–185, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Schelleman, W. B. Bilker, B. L. Strom et al., “Cardiovascular events and death in children exposed and unexposed to ADHD agents,” Pediatrics, vol. 127, no. 6, pp. 1102–1110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. N. D. Volkow, G.-J. Wang, J. S. Fowler et al., “Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma,” Psychopharmacology, vol. 166, no. 3, pp. 264–270, 2003. View at Google Scholar · View at Scopus
  6. A. N. Westover and E. A. Halm, “Do prescription stimulants increase the risk of adverse cardiovascular events? A systematic review,” BMC Cardiovascular Disorders, vol. 12, article 41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. F. M. C. Besag and G. Stiefel, “Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder,” Drug Safety, vol. 33, no. 10, pp. 821–842, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Rösler, M. Casas, E. Konofal, and J. Buitelaar, “Attention deficit hyperactivity disorder in adults,” World Journal of Biological Psychiatry, vol. 11, no. 5, pp. 684–698, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Prasad, E. Brogan, C. Mulvaney, M. Grainge, W. Stanton, and K. Sayal, “How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis,” European Child and Adolescent Psychiatry, vol. 22, no. 4, pp. 203–216, 2013. View at Publisher · View at Google Scholar · View at Scopus